SCHEMBL1695900

SCHEMBL1695900

O=C(NCC(F)(F)F)C(=Cc1ccc(Cl)cc1)c1ccc(OCc2ccccn2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP10 Q53GL7 1/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ ALOX5 P09917 1/20 0.42
▸ ALOX5AP P20292 1/20 0.42
▸ PDE10A Q9Y233 1/20 0.41
▸ LMNA P02545 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ HTT P42858 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ HPGD P15428 1/20 0.39
▸ CNR1 P21554 1/20 0.39
▸ MRGPRX4 Q96LA9 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ MAPK14 Q16539 2/20 0.38
▸ SMO Q99835 2/20 0.38
▸ P2RX3 P56373 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1695898 1.00 PARP10 (0.47) PARP10SMN1; SMN2ALDH1A1KDM4ENPC1
SCHEMBL1695462 0.85 PARP10 (0.51) PARP10SMN1; SMN2ALDH1A1KDM4ENPC1
SCHEMBL1695460 0.85 PARP10 (0.51) PARP10SMN1; SMN2ALDH1A1KDM4ENPC1
SCHEMBL1695635 0.84 PARP10 (0.46) PARP10SMN1; SMN2ALDH1A1KDM4ENPC1
SCHEMBL1695633 0.84 PARP10 (0.46) PARP10SMN1; SMN2ALDH1A1KDM4ENPC1
SCHEMBL7705577 0.82 PARP10 (0.60) PARP10SMN1; SMN2ALDH1A1KDM4ENPC1
SCHEMBL7705364 0.82 PARP10 (0.60) PARP10SMN1; SMN2ALDH1A1KDM4ENPC1
SCHEMBL1695730 0.79 PARP10 (0.44) PARP10SMN1; SMN2ALDH1A1KDM4ENPC1
SCHEMBL1695733 0.79 PARP10 (0.44) PARP10SMN1; SMN2ALDH1A1KDM4ENPC1
SCHEMBL7705433 0.77 PDE10A (0.52) PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011138657-A1 ARYL SUBSTITUTED OLEFINIC COMPOUNDS AS PDE10A INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2011-11-10 — — WO disclosed
Send feedback